{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:43:11Z","timestamp":1788892991555,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroradiology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.neurad.2025.101351","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T19:30:59Z","timestamp":1747251059000},"page":"101351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and safety of intra-arterial chemoperfusion as palliative treatment of symptomatic primary brain malignancies"],"prefix":"10.1016","volume":"52","author":[{"given":"Thomas J.","family":"Vogl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon Vincent","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"R\u00f6del","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2365-8334","authenticated-orcid":false,"given":"John","family":"Bielfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamzah","family":"Adwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurad.2025.101351_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.neurad.2025.101351_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4155\/tde-2021-0073","article-title":"Superselective intra-arterial cerebral infusion to improve brain tumor drug delivery","volume":"13","author":"Rechberger","year":"2022","journal-title":"Ther Deliv"},{"issue":"4","key":"10.1016\/j.neurad.2025.101351_bib0003","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41582-022-00621-0","article-title":"Advances in local therapy for glioblastoma - taking the fight to the tumour","volume":"18","author":"van Solinge","year":"2022","journal-title":"Nat Rev Neurol"},{"issue":"Supplement_5","key":"10.1016\/j.neurad.2025.101351_bib0004","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","article-title":"CBTRUS statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2015\u20132019","volume":"24","author":"Ostrom","year":"2022","journal-title":"Neuro-Oncol"},{"issue":"1","key":"10.1016\/j.neurad.2025.101351_bib0005","first-page":"12","article-title":"Cancer statistics","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.1016\/j.neurad.2025.101351_bib0006","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/jama.2023.0023","article-title":"Glioblastoma and other primary brain malignancies in adults: a review","volume":"329","author":"Schaff","year":"2023","journal-title":"JAMA"},{"issue":"suppl_3","key":"10.1016\/j.neurad.2025.101351_bib0007","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/nox036.023","article-title":"OS04.3 Extent of resection and overall survival in risk adjusted and exact matched analyses of 22,928 glioblastoma (all molecular subtypes) patients","volume":"19","author":"Iorgulescu","year":"2017","journal-title":"Neuro-Oncol"},{"issue":"4","key":"10.1016\/j.neurad.2025.101351_bib0008","first-page":"299","article-title":"Management of glioblastoma: state of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"23","key":"10.1016\/j.neurad.2025.101351_bib0009","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial","volume":"318","author":"Stupp","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.neurad.2025.101351_bib0010","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"Weller","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"10.1016\/j.neurad.2025.101351_bib0011","article-title":"Treatment options for progression or recurrence of glioblastoma: a network meta-analysis. Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group, ed","volume":"2021","author":"McBain","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.neurad.2025.101351_bib0012","article-title":"Procarbazine, lomustine and vincristine for recurrent high-grade glioma. Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group, ed","volume":"2017","author":"Parasramka","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.neurad.2025.101351_bib0013","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/neuonc\/nov145","article-title":"Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection","volume":"18","author":"Ringel","year":"2016","journal-title":"Neuro-Oncol"},{"issue":"1","key":"10.1016\/j.neurad.2025.101351_bib0014","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1014498225405","article-title":"Intra-arterial carboplatin and intravenous etoposide for the treatment of recurrent and progressive non-GBM gliomas","volume":"56","author":"Newton","year":"2002","journal-title":"J Neurooncol"},{"issue":"2","key":"10.1016\/j.neurad.2025.101351_bib0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11060-021-03851-2","article-title":"Repeated superselective intraarterial bevacizumab after blood brain barrier disruption for newly diagnosed glioblastoma: a phase I\/II clinical trial","volume":"155","author":"Patel","year":"2021","journal-title":"J Neurooncol"},{"issue":"5","key":"10.1016\/j.neurad.2025.101351_bib0016","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s100720200044","article-title":"Intra-arterial ACNU and carboplatin versus intravenous chemotherapy with cisplatin and BCNU in newly diagnosed patients with glioblastoma","volume":"23","author":"Silvani","year":"2002","journal-title":"Neurol Sci"},{"issue":"1","key":"10.1016\/j.neurad.2025.101351_bib0017","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1006457502972","article-title":"Randomized comparison of intra-arterial versus intravenous infusion of ACNU for newly diagnosed patients with glioblastoma","volume":"49","author":"Kochi","year":"2000","journal-title":"J Neurooncol"},{"issue":"1\u20132","key":"10.1016\/j.neurad.2025.101351_bib0018","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000346580","article-title":"Intra-arterial chemotherapy is not superior to intravenous chemotherapy for malignant gliomas: a systematic review and meta-analysis","volume":"70","author":"Chen","year":"2013","journal-title":"Eur Neurol"},{"issue":"4","key":"10.1016\/j.neurad.2025.101351_bib0019","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3109\/02688697.2013.877122","article-title":"The role of intra-arterial chemotherapy as an adjuvant treatment for glioblastoma","volume":"28","author":"Theodotou","year":"2014","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.neurad.2025.101351_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.950167","article-title":"A systematic review on intra-arterial cerebral infusions of chemotherapeutics in the treatment of glioblastoma multiforme: the state-of-the-art","volume":"12","author":"Pinkiewicz","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.neurad.2025.101351_bib0021","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejca.2016.03.082","article-title":"RECIST 1.1 \u2013 Standardisation and disease-specific adaptations: perspectives from the RECIST Working Group","volume":"62","author":"Schwartz","year":"2016","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.neurad.2025.101351_bib0022","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/159101991101700302","article-title":"Intra-arterial chemotherapy for malignant gliomas: a critical analysis","volume":"17","author":"Burkhardt","year":"2011","journal-title":"Interv Neuroradiol"},{"issue":"1","key":"10.1016\/j.neurad.2025.101351_bib0023","doi-asserted-by":"crossref","first-page":"vdac104","DOI":"10.1093\/noajnl\/vdac104","article-title":"Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors","volume":"4","author":"Uluc","year":"2022","journal-title":"Neuro-Oncol Adv"},{"issue":"13","key":"10.1016\/j.neurad.2025.101351_bib0024","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.3390\/cancers14133217","article-title":"The role of microRNAs in multidrug resistance of glioblastoma","volume":"14","author":"Mahinfar","year":"2022","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.neurad.2025.101351_bib0025","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1073\/pnas.91.6.2076","article-title":"Convection-enhanced delivery of macromolecules in the brain","volume":"91","author":"Bobo","year":"1994","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"10.1016\/j.neurad.2025.101351_bib0026","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/neuonc\/nop054","article-title":"Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma","volume":"12","author":"Kunwar","year":"2010","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.neurad.2025.101351_bib0027","article-title":"Apatinib for recurrent\/progressive glioblastoma multiforme: a salvage option","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.neurad.2025.101351_bib0028","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3390\/neurolint15010018","article-title":"Preclinical research on focused ultrasound-mediated blood-brain barrier opening for neurological disorders: a review","volume":"15","author":"Kong","year":"2023","journal-title":"Neurol Int"},{"key":"10.1016\/j.neurad.2025.101351_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114043","article-title":"Towards controlled drug delivery in brain tumors with microbubble-enhanced focused ultrasound","volume":"180","author":"Schoen","year":"2022","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Journal of Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0150986125001099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0150986125001099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:52:32Z","timestamp":1778669552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0150986125001099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0150986125001099"],"URL":"https:\/\/doi.org\/10.1016\/j.neurad.2025.101351","relation":{},"ISSN":["0150-9861"],"issn-type":[{"value":"0150-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of intra-arterial chemoperfusion as palliative treatment of symptomatic primary brain malignancies","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroradiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurad.2025.101351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101351"}}